£1 million award for BactiVac network to continue supporting development of bacterial vaccines

Bacterial infections kill over 7 million people each year and the development of new and better vaccines will reduce this devastating burden of disease. 

BactiVac, the Bacterial Vaccines Network, has secured £1 million of funding from Wellcome to accelerate the development of bacterial vaccines and combat the threat of antimicrobial resistance (AMR).